A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma

Clinical trial NCT04194801 · COMPLETED

Trial details

NCT number: NCT04194801
Sponsor: CStone Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-12-16
Primary completion: 2021-10-20
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.